Thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), ERCC1, & thymidine phosphorylase gene expression in primary & metastatic (met) colorectal cancer (CRC) tissue in patients (pts) treated on a phase I trial of oxaliplatin (OX) & capecitabine (Xel)

Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine

BMC Cancer ◽

10.1186/1471-2407-8-386 ◽

2008 ◽

Vol 8 (1) ◽

Cited By ~ 30

Author(s):

Kazumi Uchida ◽

Peter V Danenberg ◽

Kathleen D Danenberg ◽

Jean L Grem

Keyword(s):

Gene Expression ◽

Phase I ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Phase I Trial ◽

Dihydropyrimidine Dehydrogenase

283 Evaluation of thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA levels in colorectal cancer reveals significant correlations to tumor histopathology and disease-free survival in 5-FU treated patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90316-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S87

Author(s):

S. Lassmann ◽

M. Hennig ◽

R. Rosenberg ◽

J. Nährig ◽

J. Schreglmann ◽

...

Keyword(s):

Colorectal Cancer ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Disease Free Survival ◽

Mrna Levels ◽

Free Survival ◽

Disease Free

Correlation of thymidine phosphorylase (TP), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) expression in primary and metastatic sites with response to capecitabine plus irinotecan in patients with colorectal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3520 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3520-3520

Author(s):

N. J. Meropol ◽

P. J. Gold ◽

R. B. Diasio ◽

Y.-M. Chen ◽

T. Godfrey ◽

...

Keyword(s):

Colorectal Cancer ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Metastatic Sites

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdm599 ◽

2008 ◽

Vol 19 (5) ◽

pp. 915-919 ◽

Cited By ~ 92

Author(s):

R. Soong ◽

N. Shah ◽

M. Salto-Tellez ◽

B.C. Tai ◽

R.A. Soo ◽

...

Keyword(s):

Colorectal Cancer ◽

Protein Expression ◽

Cancer Patients ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Prognostic Significance ◽

Correlation of thymidine phosphorylase (TP), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) expression in primary and metastatic sites with response to capecitabine plus irinotecan in patients with colorectal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3520 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3520-3520 ◽

Cited By ~ 1

Author(s):

N. J. Meropol ◽

P. J. Gold ◽

R. B. Diasio ◽

Y.-M. Chen ◽

T. Godfrey ◽

...

Keyword(s):

Colorectal Cancer ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Metastatic Sites

Predictive Role of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase and Thymidine Phosphorylase Expression in Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil

Oncology ◽

10.1159/000098110 ◽

2006 ◽

Vol 70 (5) ◽

pp. 366-377 ◽

Cited By ~ 70

Author(s):

M. Ciaparrone ◽

M. Quirino ◽

G. Schinzari ◽

G. Zannoni ◽

D.C. Corsi ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Predictive Role ◽

Thymidine Phosphorylase Expression ◽

Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients

Pharmacogenetics and Genomics ◽

10.1097/01.fpc.0000230410.07899.bc ◽

2006 ◽

Vol 16 (11) ◽

pp. 809-816 ◽

Cited By ~ 21

Author(s):

Federica Amatori ◽

Antonello Di Paolo ◽

Mario Del Tacca ◽

Gabriella Fontanini ◽

Francesca Vannozzi ◽

...

Keyword(s):

Colorectal Cancer ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Thymidine Phosphorylase Expression

Normal Mucosa ◽

A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-0421 ◽

2018 ◽

Vol 24 (24) ◽

pp. 6160-6167 ◽

Cited By ~ 13

Author(s):

Valerie Lee ◽

Judy Wang ◽

Marianna Zahurak ◽

Elske Gootjes ◽

Henk M. Verheul ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase I Trial ◽

Association Between p53 Expression and Bcl-2, P-glycoprotein, Topoisomerase II Alpha, Thymidylate Synthase and Thymidine Phosphorylase as Potential Therapeutic Targets in Colorectal Cancer Patients

Pakistan Journal of Biological Sciences ◽

10.3923/pjbs.2007.3350.3355 ◽

2007 ◽

Vol 10 (19) ◽

pp. 3350-3355 ◽

Cited By ~ 6

Author(s):

Sepideh Arbabi Bid ◽

Ebrahim Azizi ◽

Mansour Djamali Za

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Thymidylate Synthase ◽

Thymidine Phosphorylase ◽

Topoisomerase Ii ◽

Therapeutic Targets ◽

Topoisomerase Ii Alpha ◽

P53 Expression ◽

P Glycoprotein ◽

Safety run-in evaluation of the phase I trial of trifluridine/tipiracil (FTD/TPI) in combination with oxaliplatin and a monoclonal antibody (bevacizumab or nivolumab) in patients (pts) with metastatic colorectal cancer (mCRC)

Annals of Oncology ◽

10.1093/annonc/mdy281.018 ◽

2018 ◽

Vol 29 ◽

pp. viii157-viii158 ◽

Cited By ~ 1

Author(s):

A. Calvo Ferrandiz ◽

L. Dahan ◽

A. Hollebecque ◽

G. Prager ◽

T. Andre ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Phase I Trial